Phase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin(SOX)+bevacizumab regimen for advanced colorectal cancer
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Bevacizumab; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions
- Acronyms B-Tune study
- 13 Oct 2017 Trial design presented at the 42nd European Society for Medical Oncology Congress.
- 08 Sep 2017 According to the Trial design presented at the 42nd European Society for Medical Oncology Congress, 21 patients have undergone enrollment at the time of submission of the present abstract
- 22 Oct 2014 New trial record